Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic

Shikha Garg; Sandra S Chaves; Alejandro Pérez; Tiffany D'Mello; Ken Gershman; James Meek; Kimberly Yousey-Hindes; Kathryn E Arnold; Monica M Farley; Leslie Tengelsen; Patricia Ryan; Ruta Sharangpani; Ruth Lynfield; Craig Morin; Joan Baumbach; Emily B Hancock; Shelley Zansky; Nancy M Bennett; Brian Fowler; Kristy Bradley; Ann Thomas; Tara Cooper; William Schaffner; Rachelle Boulton; Lyn Finelli; Alicia M Fry

doi:10.1093/cid/cis442

Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic

Clin Infect Dis. 2012 Aug;55(3):e18-21. doi: 10.1093/cid/cis442. Epub 2012 Apr 27.

Affiliation

¹ Epidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

PMID: 22543024
DOI: 10.1093/cid/cis442

Abstract

Influenza antiviral treatment is recommended for all persons hospitalized with influenza virus infection. During the 2010-2011 influenza season, antiviral treatment of children and adults hospitalized with laboratory-confirmed influenza declined significantly compared with treatment during the 2009 pandemic (children, 56% vs 77%; adults, 77% vs 82%; both P < .01).

Publication types

Research Support, U.S. Gov't, P.H.S.

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Antiviral Agents / administration & dosage*
Child
Child, Preschool
Drug Utilization / statistics & numerical data*
Female
Hospitalization
Humans
Infant
Infant, Newborn
Influenza, Human / drug therapy*
Influenza, Human / virology*
Male
Middle Aged
Orthomyxoviridae / isolation & purification*
Young Adult

Substances

Antiviral Agents